MedPath

Gadodiamide

Generic Name
Gadodiamide
Brand Names
Omniscan
Drug Type
Small Molecule
Chemical Formula
C16H26GdN5O8
CAS Number
131410-48-5
Unique Ingredient Identifier
84F6U3J2R6

Overview

Gadodiamide is a paramagnetic gadolinium-based contrast agent (GBCA) that is used in MR imaging procedures to assist in the visualization of blood vessels. It is intravenously injected and is commonly marketed under the trade name Omniscan.

Background

Gadodiamide is a paramagnetic gadolinium-based contrast agent (GBCA) that is used in MR imaging procedures to assist in the visualization of blood vessels. It is intravenously injected and is commonly marketed under the trade name Omniscan.

Indication

For intravenous use in MRI to visualize lesions with abnormal vascularity (or those thought to cause abnormalities in the blood-brain barrier) in the brain (intracranial lesions), spine, and associated tissues.

Associated Conditions

  • Stenosis
  • Abnormal vascularity

FDA Approved Products

OMNISCAN
Manufacturer:GE Healthcare Inc.
Route:INTRAVENOUS
Strength:287 mg in 1 mL
Approved: 2018/10/25
NDC:0407-0690
OMNISCAN
Manufacturer:GE Healthcare Inc.
Route:INTRAVENOUS
Strength:287 mg in 1 mL
Approved: 2024/01/31
NDC:0407-0690
OMNISCAN
Manufacturer:GE Healthcare Inc.
Route:INTRAVENOUS
Strength:287 mg in 1 mL
Approved: 2024/01/31
NDC:0407-0691

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath